Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
28.99
-0.11 (-0.38%)
May 20, 2026, 11:30 AM CST
Market Cap12.89B +94.4%
Revenue (ttm)1.00B +45.7%
Net Income98.39M
EPS0.24
Shares Out442.94M
PE Ratio121.93
Forward PEn/a
Dividend0.06 (0.20%)
Ex-Dividend DateMay 14, 2026
Volume4,955,231
Average Volume11,648,787
Open28.83
Previous Close29.10
Day's Range28.75 - 29.61
52-Week Range17.03 - 44.99
Beta0.80
RSI39.49
Earnings DateApr 30, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 1,002
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements